IP Verse

Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna - EP4066857B1

PatentPatent Analysis

EP4066857

GLAXOSMITHKLINE
Application Number
EP22174932A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Nov 18, 2022
Grant Date
Dec 21, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4226941B1
EP3682884B1
EP3480209B1

Bibliography

The patent EP4066857B1 was granted to Glaxosmithkline on Dec 21, 2022 following the initial filing on Aug 31, 2011 under the application number EP22174932A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSSep 21, 2023ADMISSIBLE
THOMANNSep 21, 2023ADMISSIBLE
WEICKMANN & WEICKMANNSep 20, 2023ADMISSIBLE
SANOFISep 19, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents